Meeting
2016 Genitourinary Cancers Symposium
Analysis of mutational status in recurrently mutated genes in clear cell renal cell carcinoma and overall survival in patients with metastatic disease at time of nephrectomy.
Authors
Brandon Manley
Memorial Sloan Kettering Cancer Center, New York, NY
Brandon Manley , Jozefina Casuscelli , Daniel Tennenbaum , A. Ari Hakimi , James Hsieh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 520)
DOI
10.1200/jco.2016.34.2_suppl.520
Abstract #
520
Poster Bd #
E3
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
The genomic landscape of metastatic clear cell renal cell carcinoma (ccRCC) after treatment with systemic therapy.
First Author: Johannes Van Der Mijn
Poster
2016 Genitourinary Cancers Symposium
Assessing the frequency of somatic mutations in high-risk clear cell renal cell carcinoma to provide new perspectives.
First Author: Brandon Manley
Poster
2022 ASCO Genitourinary Cancers Symposium
Tumor genomic landscape in younger compared to older patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Nishita Tripathi
Poster
2019 ASCO Quality Care Symposium
Efficacy of systemic treatment for metastatic renal cell carcinoma (mRCC) guided by comprehensive genomic profiling (CGP).
First Author: Paulo Gustavo Bergerot